Figure 7.
The relationships between the immune related risk signature and (a) tumor burden; (b) T stage; (c) M stage; (d) N stage; (e) age; (f) histological type; (g) grade; and (h) clinical stage.
The relationships between the immune related risk signature and (a) tumor burden; (b) T stage; (c) M stage; (d) N stage; (e) age; (f) histological type; (g) grade; and (h) clinical stage.